Biochemistry: Concepts and Connections (2nd Edition)
2nd Edition
ISBN: 9780134641621
Author: Dean R. Appling, Spencer J. Anthony-Cahill, Christopher K. Mathews
Publisher: PEARSON
expand_more
expand_more
format_list_bulleted
Concept explainers
Textbook Question
Chapter 6, Problem 15P
It has been postulated that the normal (noninfectious) form of prion differs from the infectious form only in secondary/tertiary structure.
a. How might you show that changes in secondary structure occur?
b. If this model is correct, what are the implications for structural prediction schemes?
Expert Solution & Answer
Trending nowThis is a popular solution!
Students have asked these similar questions
It has been postulated that the normal (noninfectious) form of prion differsfrom the infectious form only in secondary/tertiary structure.(a) How might you show that changes in secondary structure occur?(b) If this model is correct, what are the implications for structural prediction schemes?
Various antimicrobial drugs to treat microbial infection have diverse mechanism of action. Consider the following antimicrobial drugs:
A. Seconeolitsine, known as DNA topoisomerase I inhibitor in bacteria.
(i) Explain briefly how inhibiting DNA topoisomerase I is a good mechanism of action for an antibiotic, include possible molecular machineries being targeted.
(ii) What would be an appropriate response if seconeolitsine works well by stating the state of supercoiling in bacteria.
(iii) To prove your answer (ii), you test the condition of bacterial DNA by running gel electrophoresis, one has been treated with seconeolitsine (+ sample) and the other one is not (- sample). Explain the position of each + sample and – sample band on the gel in reference to the point of origin (where you load your samples) or how far each DNA sample travel across agarose gel.
(iv) Explain why you would expect answer (iii) for each + sample and – sample.
B.…
Among the following statements regarding the use of viral vectors, which is (are) true: (can be more then one answer)
A.Viral vector transfection has the defect of rapidly killing cells, given the high toxic potential of viruses.
B.Generally, the effectiveness of a viral infection transfection is much higher than an electroporation or cationic liposome transfection.
C.Even before infecting a cell, a virus can begin to express the indicators, accelerating the process of expression of the indicator in the culture medium.
D.Adeno-associated viruses are little used in biophotonics, as they require simultaneous adenovirus infection.
Chapter 6 Solutions
Biochemistry: Concepts and Connections (2nd Edition)
Ch. 6 - Prob. 1PCh. 6 - Bovine pancreatic trypsin inhibitor (BPTI; Figure...Ch. 6 - A schematic structure of the subunit of...Ch. 6 - In the protein adenylate kinase, the C-terminal...Ch. 6 - Give two reasons to explain why a proline residue...Ch. 6 - Consider a small protein containing 101 amino acid...Ch. 6 - a. Based on a more conservative answer to Problem...Ch. 6 - The following sequence is part of a globular...Ch. 6 - a. A protein is found to be a tetramer of...Ch. 6 - Under physiological conditions, the protein...
Ch. 6 - Theoretical and experimental measurements show...Ch. 6 - The peptide hormone vasopressin is used in the...Ch. 6 - A protein gives under conditions of buffer...Ch. 6 - A protein gives a single band on SDS get...Ch. 6 - It has been postulated that the normal...Ch. 6 - Below are shown two views of the backbone...Ch. 6 - Do you expect a Pro Gly mutation in a...Ch. 6 - Rank the following in terms of predicted rates...Ch. 6 - Shown below are two cartoon views of the small...Ch. 6 - Prob. 20PCh. 6 - In most cases, mutations in the core of protein...Ch. 6 - A Leu Ala mutation at a site buried the core of...Ch. 6 - Disulfide bonds have been shown to stabilize...Ch. 6 - Cartoon renderings of the proteins Top 7 and adaH2...
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biochemistry and related others by exploring similar questions and additional content below.Similar questions
- SET 1: PEPTIDE SEQUENCING BY ENZYME DEGRADATION AND EDMANN TECHNIQUE A. Predict the fragments that will be generated from the treatment of the following peptide with: a.) trypsin b.) chymotrypsin c.) and S. aureus V8 protease G-A-W-R-N-A-K-E-F-G-Q WRITE the fragments in this table: trypsin chymotrypsin S. aureus V8 protease G-A-W-R; N-A-K; E-F-G-Q G-A-W; R-N-A-K-E-F; G-Q G-A-W-R-N; A-K-E; F-G-Q B. The sequence of a 29 aa long peptide can be determined from the following data: Treatment of the peptide with dansyl chloride reveals that the amino terminal is Val. а. b. Trypsin digestion, separation of peptides, and Edmann technique give the sequences for peptide fragments as follows: T1 V-G-A-H-A-G-E-Y-G-A-E-A-T-E C- Terminal Peptide fragment T2 A-A-W-G-K & T4 T-N-V-K middle peptide fragments T3 V-L-S-P-A-K N-Terminal Peptide fragment c. Chymotrypsin digestion, separation of peptides, and Edmann technique give the sequences for peptide fragments as follows: C1 G-A-E-A-T-E C- Terminal…arrow_forwardThe macrolide below is a bacteria produced toxin. The primer was acetyl-Co-A. Three possible extenders are also shown A) malonate-Co-A B) methylmalonate-Co-A and C) ethylmalonate- Со-А. Indicate which extenders were used using this format: XA yB zC Meaning x molecules of A, y molecules of B and z molecules of C он COA CH3 А А но CH3 CoA В но ČH3 H3C C C HO но COA CH3 Enter Your Answer:arrow_forward5 25) Although the UV280 extinction coefficient of BSA is well known, why was the BCA assay employed to measure protein concentration of the folate labeled BSA? Please provide an explanation. (C) Would the use of reducing agents have an affect on the tertiary structure of BSA—please explain your answer (you will need to investigate the structure of BSA beyond this article)?arrow_forward
- 3) The ACE2 receptor protein in humans has been getting a lot of press these days, as it apparently serves as a "receptor" for the SARS-CoV-2 coronavirus in addition to its normal functions. This protein has an isoelectric pH of 5.36. Suppose you want to purify this protein to study its properties, with the goal of developing a drug that would block it from binding the virus. Once you have purified the cell surface proteins from your cultured human lung cells away from all the other types of molecules in the cell, and all the cytoplasmic proteins, you might decide to use ion exchange chromatography to separate the ACE2 proteins from other proteins in your sample. If you plan to load your protein mixture onto your ion exchange column in a buffer at pH 7.4 (approximately physiological pH) and you want the ACE2 proteins to bind to the column, should you use a resin with a positive charge or a negative charge? Briefly explain why you chose the resin you selected.arrow_forwardThe molecular weight of the RNA of poliovirus is 2.6x106 amu. How long would it take for it to travel the distance between two conversing people 1.0 m apart by diffusion in still air? (use very rough assumptions: density of spherical virus is 1 gm cm-3 and viscosity of air 1.0x10-5)arrow_forwardGive three reasons why liposomes/nanoparticles are attractive drug delivery system for recombinant protein preparations?arrow_forward
- You have an extract of BL21(DE3) cells containing a soluble, 75 kDa recombinant protein that has a histidine tail at its C-terminus. This extract is still in raw form and you need to purify this protein without losing its solubility. Check the option below that represents the best purification methodology in the order of execution. * a) (1) isoelectric precipitation; (2) microfiltration; (3) affinity chromatography; (4) anion exchange chromatography b) (1) centrifugation; (2) microfiltration; (3) isoelectric precipitation; (4) affinity chromatography c) (1) centrifugation; (2) microfiltration; (3) affinity chromatography; (4) ultrafiltration d) (1) microfiltration; (2) jumping out; (3) centrifugation; (4) affinity chromatographyarrow_forwardHelp mearrow_forwardA conjugate was incubated with a mixture of lysosomal enzymes and no drug release was observed in these conditions. The same conjugate was tested for antitumor activity in vivo and an anticancer effect was observed. Taking into account the information provided above, hypothesize a possible mechanism of action for this conjugate.arrow_forward
- The macrolide below is a bacteria produced toxin. The primer was acetyl-Co-A. Three possible extenders are also shown A) malonate-Co-A B) methylmalonate-Co-A and C) ethylmalonate-Co-A. Indicate which extenders were used using this format: XA yB zC Meaning x molecules of A, y molecules of B and z molecules of C A COA но CH3 но, CH3 COA H3C CH3 B но HO CH3 CH3 HO CH3 C COA но CH3 Enter Your Answer:arrow_forwardThe synthetic antiviral drug Tamifl u, currently the most effective agent against avian infl uenza, is prepared by a 10-step synthesis. What is the overall yield of Tamifl u in each of the following 10-step syntheses? a. Each step proceeds in 90.% yield. b. Each step proceeds in 80.% yield. c. One step proceeds in 50.% yield, while the rest occur in 90.% yield. d. The following yields are recorded: 20.% (one reaction), 50.% (two reactions), 80.% (all remaining reactions).arrow_forward(a) Answer all sections (i)- (Iv). Below is given the structure of three anti-HIV drugs: OH Meo. OMe NH Ph Nevirapine Atazanavir Staudivine (i) Give the drug target and discuss the anti-HIV mechanism of each of these drugs. Vaccines are an attractive prophylactic treatment against both viral and bacterial diseases. A number of glycaconjugate vaccines using bacterial polysaccharide structures conjugated to protein carriers have been introduced into mass vaccination schemes with excellent results. What differences are there in the immune response to a glycoconjugate vaccine as compared to a polysaccharide vaccine? These glycoconjugate va nes has been used for 30 years without any change in their structures, while the composition of the flu vaccine, based on attenuated or killed virus particies, is changed from year to year. Discuss the reason behind this. (iv) Discuss why it has not been possible to develop a (part structure) vaccine against the HIV virus, based on either I) viral…arrow_forward
arrow_back_ios
SEE MORE QUESTIONS
arrow_forward_ios
Recommended textbooks for you
- BiochemistryBiochemistryISBN:9781319114671Author:Lubert Stryer, Jeremy M. Berg, John L. Tymoczko, Gregory J. Gatto Jr.Publisher:W. H. FreemanLehninger Principles of BiochemistryBiochemistryISBN:9781464126116Author:David L. Nelson, Michael M. CoxPublisher:W. H. FreemanFundamentals of Biochemistry: Life at the Molecul...BiochemistryISBN:9781118918401Author:Donald Voet, Judith G. Voet, Charlotte W. PrattPublisher:WILEY
- BiochemistryBiochemistryISBN:9781305961135Author:Mary K. Campbell, Shawn O. Farrell, Owen M. McDougalPublisher:Cengage LearningBiochemistryBiochemistryISBN:9781305577206Author:Reginald H. Garrett, Charles M. GrishamPublisher:Cengage LearningFundamentals of General, Organic, and Biological ...BiochemistryISBN:9780134015187Author:John E. McMurry, David S. Ballantine, Carl A. Hoeger, Virginia E. PetersonPublisher:PEARSON
Biochemistry
Biochemistry
ISBN:9781319114671
Author:Lubert Stryer, Jeremy M. Berg, John L. Tymoczko, Gregory J. Gatto Jr.
Publisher:W. H. Freeman
Lehninger Principles of Biochemistry
Biochemistry
ISBN:9781464126116
Author:David L. Nelson, Michael M. Cox
Publisher:W. H. Freeman
Fundamentals of Biochemistry: Life at the Molecul...
Biochemistry
ISBN:9781118918401
Author:Donald Voet, Judith G. Voet, Charlotte W. Pratt
Publisher:WILEY
Biochemistry
Biochemistry
ISBN:9781305961135
Author:Mary K. Campbell, Shawn O. Farrell, Owen M. McDougal
Publisher:Cengage Learning
Biochemistry
Biochemistry
ISBN:9781305577206
Author:Reginald H. Garrett, Charles M. Grisham
Publisher:Cengage Learning
Fundamentals of General, Organic, and Biological ...
Biochemistry
ISBN:9780134015187
Author:John E. McMurry, David S. Ballantine, Carl A. Hoeger, Virginia E. Peterson
Publisher:PEARSON
What Is A Virus ? ; Author: Peekaboo Kidz;https://www.youtube.com/watch?v=YS7vsBgWszI;License: Standard YouTube License, CC-BY